Viking Therapeutics VKTX is taking another step toward expanding its presence in the obesity space. The company recently initiated phase III development of the oral formulation of VK2735, its lead ...

ATLANTA — Upcoming evidence-based clinical guidelines from three obesity organizations will address US-based pharmacologic management of overweight/obesity and its complications in adults. A preview ...

Foundayo is on course to join Novo’s oral Wegovy in the European oral GLP-1RA market.

The popularity of glucagon-like peptide-1 (GLP-1) agonists like Ozempic, Wegovy and Mounjaro has exploded in recent years. Initially approved to treat Type 2 diabetes, the drugs have become the tool ...

Al Ahli Hospital has successfully hosted its Second Diabetes and Endocrinology Conference at the Sheraton Grand Doha Resort ...

Patient interactions are an important element of obesity case management, and proactive strategies and communication can enhance patients' health routines. These strategies can include patient-centric ...

Top obesity support organizations like Obesity Action Coalition, American Obesity Foundation, and Overeaters Anonymous help ...

Obesity is a common and important topic in family medicine, yet we often struggle to find the most effective ways to help our patients, many of whom may be reluctant to discuss it. Because weight is ...

To help clinicians navigate discontinuation after patients achieve their weight loss goals, and given the absence of robust evidence or guidelines, we propose three discontinuation strategies: dose de ...

The World Health Organization (WHO) today released its first guidelines addressing the sharp rise in obesity among children and adolescents, setting out how health systems and health workers can ...